Form 4 for CRVS Corvus Pharmaceuticals, Inc.
Accepted 2024-05-14 00:00:00 ET · period of report 2024-05-10 · accession 0001610717-24-000237 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-05-14 | 2024-05-10 | CRVS | MILLER RICHARD A MD | Pres, CEO, Dir | G - Gift | $0.00 | -302.0K | 1.19M | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-10 | G | D | 302,016 | $0.00 | 1,188,103 | I By Trust | — | — | (F1) These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. |